Founder Effect of the c. 500G >A Variant in South Asian Patients With Inherited GPD1 Deficiency: Report on 16 Patients and Variant Review
American Journal of Medical Genetics Part A · 2026-08 · 200 (8) · 1753-1759
DOI: 10.1002/ajmg.a.70129 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 16.03.2026. Verfasst von Ishaq Malik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Government Medical College, Srinagar, Kashmir, India. Hauptthemen laut MEDLINE: Founder Effect, Glycerol-3-Phosphate Dehydrogenase (NAD+), Glycerolphosphate Dehydrogenase, Hypertriglyceridemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Only a few studies describe five (or more) patients with inherited glycerol‐3‐phosphate dehydrogenase 1 (GPD1) deficiency, often termed transient infantile hypertriglyceridemia (HTGTI). We report 18 additional patients with HTGTI (confirmed molecular diagnosis in 16, a variant of uncertain significance in two), most of whom presented in infancy with hepatomegaly. A significant negative correlation was noted between age at presentation and serum triglyceride levels. Except for two, all our patients have homozygous GPD1 variants, wherein the c.500G>A (p.Gly167Asp) variant was the most common (10 patients). Other variants identified included c.220‐1G>T, c.398C>T (p.Ser133Leu, unpublished), c.806G>A (p.Arg269Gln), and c.685C>T (p.Arg229Trp, novel). Homozygosity matching in patients with the biallelic c.500G>A variant showed that the GPD1 gene is located within the only shared region of homozygosity (> 1 Mb). These patients also have a similar homozygous haplotype around the variant, construing its founder effect in South Asian patients with inherited GPD1 deficiency. Targeted testing for c.500G>A could be considered as a first‐tier evaluation strategy in South Asian patients with HTGTI. However, given our limited sample size, further validatory studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Government Medical College, Srinagar, Kashmir, India.
- Modern Hospital Super Specialty Healthcare Pvt. Ltd., Srinagar, Kashmir, India.
- Department of Pediatric Radiology, Government Medical College, Srinagar, Kashmir, India.
ORCID-Profile: Aaqib Zaffar Banday, Sahel Basharat
Zitieren
APA
Malik, I., Banday, A. Z., Bhat, A. S., Jan, U. M., Reshie, A. A., Fayaz, F., Basharat, S., & Wani, N. A. (2026). Founder Effect of the c. 500G >A Variant in South Asian Patients With Inherited GPD1 Deficiency: Report on 16 Patients and Variant Review. American Journal of Medical Genetics Part A, 200(8), 1753-1759. https://doi.org/10.1002/ajmg.a.70129
Vancouver
Malik I, Banday AZ, Bhat AS, Jan UM, Reshie AA, Fayaz F, et al. Founder Effect of the c. 500G >A Variant in South Asian Patients With Inherited GPD1 Deficiency: Report on 16 Patients and Variant Review. American Journal of Medical Genetics Part A. 2026;200(8):1753-1759. doi:10.1002/ajmg.a.70129
BibTeX
@article{Malik2026,
author = {Malik, Ishaq and Banday, Aaqib Zaffar and Bhat, Abdus Sami and Jan, Usman Muzafar and Reshie, Aisha Ashiq and Fayaz, Falah and Basharat, Sahel and Wani, Nisar Ahmad},
title = {Founder Effect of the c. 500G >A Variant in South Asian Patients With Inherited GPD1 Deficiency: Report on 16 Patients and Variant Review},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
volume = {200},
number = {8},
pages = {1753--1759},
doi = {10.1002/ajmg.a.70129}
}
EUVIMED